We are live on
!
Find out more
NRC
North Run Capital Portfolio holdings
AUM
$43.5M
1-Year Est. Return
38.24%
This Fund
S&P 500
This Quarter
Est. Return
-30.72%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$99.6M
AUM Growth
-$27.6M
(-22%)
Cap. Flow
+$24.2M
Cap. Flow
% of AUM
24.27%
Top 10 Holdings %
Top 10 Hldgs %
68.72%
Holding
26
New
5
Increased
10
Reduced
6
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MIME
Mimecast Limited
MIME
|
+$10.8M |
| 2 |
Enviri
NVRI
|
+$7.06M |
| 3 |
BXRX
Baudax Bio, Inc. Common Stock
BXRX
|
+$6.03M |
| 4 |
Salesforce
CRM
|
+$5.32M |
| 5 |
Magnachip Semiconductor
MX
|
+$4.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
|
+$10.3M |
| 2 |
Varonis Systems
VRNS
|
+$5.78M |
| 3 |
SCU
Sculptor Capital Management, Inc. Class A Common Stock
SCU
|
+$4.64M |
| 4 |
Calix
CALX
|
+$4.46M |
| 5 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 68.64% |
| 2 | Industrials | 10.2% |
| 3 | Healthcare | 8.49% |
| 4 | Communication Services | 6.34% |
| 5 | Materials | 4.79% |
Similar funds
ACM
HA
JI
CCS
BGP
EOCM
SJIA
LN
North Run Capital's Q1 2020 Portfolio in Review
As of Q1 2020, North Run Capital held 26 positions worth $99.6M, down 22% from $127M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
North Run Capital deployed $24.2M of net new capital in Q1 2020, opening 5 new positions and adding to 10 existing holdings. Its largest new stake was Mimecast Limited: 250,000 shares worth $8.82M.
By sector, the portfolio is most concentrated in Technology at 69% of assets, up from 67% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Varonis Systems, an estimated $5.78M trimmed.
- North Run Capital's largest Q1 2020 buy was Mimecast Limited: 250,000 shares worth $8.82M.
- North Run Capital added most to Baudax Bio, Inc. Common Stock in Q1 2020, an estimated $6.03M increase.
- North Run Capital's biggest Q1 2020 reduction was Varonis Systems, cutting an estimated $5.78M.
- North Run Capital fully exited ForeScout Technologies, Inc. Common Stock in Q1 2020, selling an estimated $10.3M.
- North Run Capital's ten largest holdings make up 69% of its $99.6M portfolio in Q1 2020.
- North Run Capital opened 5 new positions and closed 4 in Q1 2020.
- North Run Capital's portfolio value fell 22% quarter-over-quarter to $99.6M.
Based on North Run Capital's 13F filing for Q1 2020, filed 15 May 2020.